PPARgamma activation improves cardiac energy metabolism in patients with type 2 diabetes Mellitus

PPARgamma activation improves cardiac energy metabolism in patients with type 2 diabetes Mellitus

Dettagli Bibliografici
Autori principali:	Scheuermann-Freestone, M, Madsen, P, Buckingham, R, Styles, P, Neubauer, S, Clarke, K
Natura:	Conference item
Pubblicazione:	2003

Documenti analoghi

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
di: Scheuermann-Freestone, M, et al.
Pubblicazione: (2003)

Cardiac and skeletal muscle metabolism after chronic PPAR gamma activation in type 2 diabetes mellitus
di: Scheuermann-Freestone, M, et al.
Pubblicazione: (2004)

Abnormal cardiac high-energy phosphate metabolism in a patient with type 2 diabetes mellitus.
di: Scheuermann-Freestone, M, et al.
Pubblicazione: (2006)

Effect of chronic peroxisome proliferator-activated receptor gamma (PPAR gamma) activation on cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes mellitus
di: Scheuermann-Freestone, M, et al.
Pubblicazione: (2004)

Fatty acid metabolism in patients with PPARgamma mutations.
di: Tan, G, et al.
Pubblicazione: (2008)

Sleep apnoea is associated with impaired cardiac high-energy phosphate metabolism and abnormal diastolic function
di: Scheuermann-Freestone, M, et al.
Pubblicazione: (2006)

Does dieting affect cardiac high-energy phosphate metabolism and cardiac function? Effects of two weeks of a high-fat, low-carbohydrate diet in healthy subjects
di: Scheuermann-Freestone, M, et al.
Pubblicazione: (2006)

Abnormal cardiac energetics are associated with diastolic dysfunction in uncomplicated obesity
di: Robinson, M, et al.
Pubblicazione: (2006)

PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action
di: Miguel Hernandez-Quiles, et al.
Pubblicazione: (2021-02-01)

Abnormal cardiac and skeletal muscle function and energetics correlate with insulin resistance in heart failure
di: Scheuermann-Freestone, M, et al.
Pubblicazione: (2004)

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
di: Lygate, C, et al.
Pubblicazione: (2003)

Haemoglobin and flow-mediated vasodilation.
di: Madsen, P, et al.
Pubblicazione: (2006)

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
di: Altshuler, D, et al.
Pubblicazione: (2000)

PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease
di: Ming-Chang Chiang, et al.
Pubblicazione: (2012-01-01)

PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes.
di: Bagi, Z, et al.
Pubblicazione: (2004)

Derangement of cardiac high energy phosphate metabolism in patients with left ventricular non-compaction and preserved ejection fraction
di: Petersen, S, et al.
Pubblicazione: (2006)

Impaired cardiac energy metabolism and diastolic dysfunction in normal subjects after two weeks on a high-fat, low-carbohydrate diet
di: Freestone, MS, et al.
Pubblicazione: (2005)

Ppargamma2 is a key driver of longevity in the mouse.
di: Carmen Argmann, et al.
Pubblicazione: (2009-12-01)

PPARgamma regulates trophoblast proliferation and promotes labyrinthine trilineage differentiation.
di: Mana M Parast, et al.
Pubblicazione: (2009-11-01)

PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance
di: Vladimir T. Todorov
Pubblicazione: (2013-01-01)

Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha.
di: Jonathan Goldwasser, et al.
Pubblicazione: (2010-08-01)

PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy
di: Giuseppina Augimeri, et al.
Pubblicazione: (2021-05-01)

PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders
di: Grygiel-Górniak B, et al.
Pubblicazione: (2018-03-01)

The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.
di: Tan, G, et al.
Pubblicazione: (2006)

Influence of the body mass and visceral adiposity on glucose metabolism in obese women with Pro12Pro genotype in PPARgamma2 gene
di: Vanessa Chaia Kaippert, et al.
Pubblicazione: (2013-06-01)

De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.
di: Mohamed Sabry Hamza, et al.
Pubblicazione: (2009-01-01)

Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus
di: Levelt, E, et al.
Pubblicazione: (2015)

Hemoglobin and nitric oxide dependent vasodilation
di: Madsen, P, et al.
Pubblicazione: (2005)

Patients with obstructive sleep apnoea have impaired cardiac metabolism and diastolic dysfunction compared to controls
di: West, S, et al.
Pubblicazione: (2005)

Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism.
di: Holloway, C, et al.
Pubblicazione: (2012)

The cardiovascular changes underlying a low cardiac output with exercise in patients with type 2 diabetes mellitus
di: Per Lav Madsen, et al.
Pubblicazione: (2024-03-01)

Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance.
di: Robinson, MR, et al.
Pubblicazione: (2008)

Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance
di: Robinson, MR, et al.
Pubblicazione: (2008)

Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance
di: Robinson, M, et al.
Pubblicazione: (2008)

PPARgamma dependent PEX11beta counteracts the suppressive role of SIRT1 on neural differentiation of HESCs.
di: Maryam Esmaeili, et al.
Pubblicazione: (2024-01-01)

PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice
di: Unger Thomas, et al.
Pubblicazione: (2010-10-01)

MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus
di: Xiu Mei Ma, et al.
Pubblicazione: (2024-03-01)

Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells
di: Wallis Natalie K, et al.
Pubblicazione: (2008-12-01)

Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma).
di: Anil K Singh, et al.
Pubblicazione: (2010-03-01)

COVID-19 myopericarditis with cardiac tamponade in the absence of respiratory symptoms: a case report
di: Lauren Cairns, et al.
Pubblicazione: (2021-01-01)